drugset / Trial / NCT04427540
Oxytocin Pharmacokinetics After Intramuscular Injection
NaSingle-groupOpen-labelBasic science
Summary
In this study people with knee arthritis so severe that a joint replacement is needed are recruited for a one day study. Study participants will have an intravenous catheter (IV) inserted in the forearm. A single intramuscular (IM) injection of oxytocin (Pitocin®), 17 micrograms will be administered and blood samples will be taken several times over the next 120 minutes. The amount of oxytocin will be measured in the blood samples. The main purpose of this study is to sample the blood, before and after the administration of oxytocin and calculate the pharmacokinetics (amount of oxytocin in the blood over time) of oxytocin.
Timeline
- Start
- 2021-12
- Primary completion
- 2022-06
- Completion
- 2022-12
Outcome
Outcome not reported
Stopped (Enrollment): “Study was not initiated; no subjects were consented or enrolled”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Oxytocin | Peptide | 10 ug | Intramuscular |